A detailed history of Atria Investments LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 3,814 shares of GH stock, worth $359,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,814
Previous 4,012 4.94%
Holding current value
$359,927
Previous $208,000 14.42%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$40.98 - $67.42 $8,114 - $13,349
-198 Reduced 4.94%
3,814 $238,000
Q2 2025

Aug 04, 2025

BUY
$37.05 - $52.04 $148,644 - $208,784
4,012 New
4,012 $208,000
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $235,392 - $354,085
3,987 New
3,987 $277,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $9.65B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.